Skip to main content
. 2022 Jan 27;22:34. doi: 10.1186/s12871-022-01574-z

Table 1.

Patient Characteristics

No Sedation Midazolam Propofol Dexmedetomidine P value
Number of Patients 5 11 13 13
Age (years, Mean ± SD) 65.8 ± 7.4 63.3 ± 13.5 61.5 ± 14.2 62.8 ± 11.7 0.94
Gender
 Male 1 6 7 6 0.85
 Female 4 5 6 7
Hunt-Hess Scale
 III 4 6 8 9 0.76
 IV 1 5 5 4
Fisher Grade
 2 1 1 2 2 0.94
 3 ~ 4 4 10 11 11
WFNS SAH grading scale
 II 3 2 4 4 0.42
 III ~ V 2 9 9 9
Glasgow Outcome Scale
 Poor (1 ~ 4) 8 9 9 0.98
 Good (5) 3 4 4
RASS Before Sedation
  + 2 2 3 6 7 0.92
  + 3 2 6 5 4
  + 4 1 2 2 2
RASS After Sedation
  + 1 3 5 6 0.81
 0 5 4 5
 -1 3 4 2
Other Pharmacological Interventions
 Opioid Analgesics 2 2 4 4 0.76
 Non-Opioid Analgesics 2 2 4 4 0.76
 Mannitol 2 6 9 8 0.55
 Hyperosmotic Saline 2 7 7 7 0.79
 Insulin 3 9 8 10 0.31
 Antihypertensive Agents 3 9 10 11 0.22
 Vasoactive Agents 2 10 10 9 0.15
Comorbidity
 Acute heart failure 2 7 7 7 0.79
 Secondary Hypopituitarism 3 7 6 9 0.35
 Hypertension 1 2 4 3 0.90
 History of stroke or TIA 0 3 4 4 0.49